PhotoPill Medical
Disposable Electronic Capsule for side-effect-free treatment of Crohn's Disease.
Company Overview
Snapshot
Founded in July 2010 by Ram Ben-Yehuda and Sharon Ben Yehuda, PhotoPill Medical operates with 1–10 employees. The company has raised $3.2 million across four funding rounds. In May 2025, PhotoPill Medical launched a clinical study for its novel IBD-Cap capsule with Crohn’s Disease patients.
Business overview
PhotoPill Medical is a Health Tech & Life Sciences company developing an electronic, disposable, non-medicinal capsule that utilizes Photo-Bio Modulation treatment (PBMt) to manipulate gut-microbiota. This technology aims to provide potential treatment for various gut-microbiota affected conditions. Its flagship product, the IBD-Cap, is an ingestible electronic capsule designed to deliver PBM therapy to reduce flare-ups by treating ulcerations and inflammation associated with inflammatory bowel disease (IBD), ulcerative colitis, and Crohn's disease. The capsule is fully autonomous, requiring no preparation, external guidance, or imaging, and operates within the medical devices, digital healthcare, and digital therapeutics sectors.
Strategic signal
In May 2025, PhotoPill Medical initiated a clinical study for its IBD-Cap capsule involving Crohn's Disease patients. This development signals a significant step forward in validating the efficacy of their Photo-Bio Modulation treatment for inflammatory bowel diseases, moving the company closer to market readiness and demonstrating progress in addressing chronic patient needs within gastroenterology.
Log in to access full profile ›Company Intelligence Q&A
- What is PhotoPill Medical's core product?
- PhotoPill Medical's core product is the IBD-Cap, a disposable, ingestible electronic capsule designed to deliver Photo-Bio Modulation treatment (PBMt) for the reduction of flare-ups in inflammatory bowel disease (IBD), ulcerative colitis, and Crohn's disease.
- When was PhotoPill Medical founded?
- PhotoPill Medical was founded in July 2010.
- What is the primary medical condition PhotoPill Medical aims to treat?
- PhotoPill Medical primarily aims to treat inflammatory bowel disease (IBD), ulcerative colitis, and Crohn's disease by manipulating gut-microbiota using Photo-Bio Modulation treatment.
- What is the current stage of PhotoPill Medical's product development?
- PhotoPill Medical's product, the IBD-Cap, is currently in the clinical trial stage, with a study launched in May 2025 involving Crohn's Disease patients.
- What is the total capital raised by PhotoPill Medical?
- PhotoPill Medical has raised a total of $3.2 million across four funding rounds.